J 2021

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL et. al.

Základní údaje

Originální název

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

Autoři

CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL, D. SEIDEL, K. ALBUS, J. N. DE ALMEDIA, G. GARCIA-EFFRON, N. GILROY, C. LASS-FLORL, L. OSTROSKY-ZEICHNER, L. PAGANO, T. PAPP, R. RAUTEMAA-RICHARDSON, J. SALMANTON-GARCIA, A. SPEC, J. STEINMANN, S. ARIKAN-AKDAGLI, D. E. ARENZ, R. SPRUTE, L. DURAN-GRAEFF, Tomáš FREIBERGER (203 Česká republika, domácí), C. GIRMENIA, M. HARRIS, S. S. KANJ, M. ROUDBARY, O. LORTHOLARY, J. MELETIADIS, E. SEGAL, F. F. TUON, N. WIEDERHOLD, T. BICANIC, J. CHANDER, Y. C. CHEN, P. R. HSUEH, M. IP, P. MUNOZ, I. SPRIET, E. TEMFACK, L. THOMPSON, A. M. TORTORANO, A. VELEGRAKI a N. P. GOVENDER

Vydání

Lancet Infectious Diseases, Oxford, Elsevier SCI LTD, 2021, 1473-3099

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30303 Infectious Diseases

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 71.421

Kód RIV

RIV/00216224:14110/21:00123979

Organizační jednotka

Lékařská fakulta

UT WoS

000723373700002

Klíčová slova anglicky

rare yeast infections; diagnosis; management

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 21. 4. 2022 10:13, Mgr. Tereza Miškechová

Anotace

V originále

Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients who are immunocompromised or seriously ill. The major pathogens include those of the genera Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon (ie, basidiomycetes) and Kodamaea, Malassezia, Pseudozyma (ie, now Moesziomyces or Dirkmeia), Rhodotorula, Saccharomyces, and Sporobolomyces (ie, ascomycetes). A considered approach to the complex, multidisciplinary management of infections that are caused by these pathogens is essential to optimising patient outcomes; however, management guidelines are either region-specific or require updating. In alignment with the One World-One Guideline initiative to incorporate regional differences, experts from diverse geographical regions analysed publications describing the epidemiology and management of the previously mentioned rare yeasts. This guideline summarises the consensus recommendations with regards to the diagnostic and therapeutic options for patients with these rare yeast infections, with the intent of providing practical assistance in clinical decision making. Because there is less clinical experience of patients with rare yeast infections and studies on these patients were not randomised, nor were groups compared, most recommendations are not robust in their validation but represent insights by use of expert opinions and in-vitro susceptibility results. In this Review, we report the key features of the epidemiology, diagnosis, antifungal susceptibility, and treatment outcomes of patients with Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon spp infections.